フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today announced that it has received notification from The Nasdaq Stock Market, Inc. that the Nasdaq...
IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today provided additional information concerning its progress in filing its annual report on Form 10-K for...
IMPAX Laboratories, Inc. (Nasdaq:IPXLE) today announced that it has entered into a definitive agreement to sell $75 million aggregate principal...
IMPAX Laboratories, Inc. (Nasdaq:IPXLE) announced today that it received commitments from Wachovia Bank, National Association and Wachovia Capital...
IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today reported steps taken to complete its financial closing and file its Annual Report on Form 10-K for...
First graph, first sentence of release should read: xxx a generic version of Rimadyl(R) (Carpofen) 25, 75 and 100 mg Caplets (sted xxx a generic...
IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval to the...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約